US Patent Issued to MIRATI THERAPEUTICS on April 29 for "Crystalline forms of a KRas G12C inhibitor" (British, American Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,431, issued on April 29, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).

"Crystalline forms of a KRas G12C inhibitor" was invented by Patricia Andres (San Diego), Samuel Andrew (Cambridge, Great Britain), Cheng Yi Chen (San Diego), Susana Del Rio Gancedo (Cambridge, Great Britain), Tawfik Gharbaoui (Escondido, Calif.) and Jennifer Nelson (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to crystalline forms of a KRas G12C inhibitor and salt thereof. In particular, the present invention relates to crystalline forms of the KRas G12C inhibitor 2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-meth...